%20-%20Tint%20100.png?width=106&name=Logo%20-%20Standard%20-%20Blue%20(270%20x%20149)%20-%20Tint%20100.png){kind=logo}
Innovator Spotlight
Amplitude Vascular Systems
Matthew Boyd and Brian Johnson are joined by Dr. Robert Chisena and Sean Gilligan from Amplitude Vascular Systems. They discuss AVS’ approach to intravascular lithotripsy, their PULSE IVL technology, and more.
Amplitude Vascular Systems is an early-stage medical device company that is focused on safely and effectively treating severely calcified arterial disease. AVS is the first company to develop the Pulse IVL™ System, a device that delivers intravascular lithotripsy therapy through a balloon-based platform. It is designed to be the only minimally invasive technology that gently shatters calcium and opens the artery using a single device.
×
Please feel out the form below and someone from our team will contact you shortly.
Inside the Episode
Innovator Spotlight
Amplitude Vascular Systems
On Point
Sean Gilligan on point discussing the rapid adoption of new technology in the healthcare industry.
On Point
Robert Chisena on point discussing the benefits of adversity to entrepreneurs and start-ups.
On Point
Robert Chisena on point answering rapid fire questions from Brian Johnson.
On Point
Sean Gilligan on point discussing why a physician would choose to use AVS' Pulse IVL™ therapy.
On Point
Sean Gilligan on point discussing the impact of the Shockwave Medical acquisition on AVS.
On Point
Robert Chisena on point discussing the point of differentiation of AVS' Pulse IVL™ therapy.
On Point
Sean Gilligan on point discussing the balancing act of urgency and discipline when commercializing a medical device.
On Point
Robert Chisena on point discussing the mechanism of action behind AVS' Pulse IVL™ technology.
On Point
Sean Gilligan on point discussing the enabling technologies for intravascular lithotripsy.
On Point
Robert Chisena on point discussing AVS' path from university lab to venture funded start-up.
On Point
Robert Chisena on point discussing the benefits of proximity for biomedical engineering programs to healthcare systems.
On Point
Sean Gilligan on point discussing the rapid adoption of new technology in the healthcare industry.
On Point
Robert Chisena on point discussing the benefits of adversity to entrepreneurs and start-ups.
On Point
Robert Chisena on point answering rapid fire questions from Brian Johnson.
On Point
Sean Gilligan on point discussing why a physician would choose to use AVS' Pulse IVL™ therapy.
On Point
Sean Gilligan on point discussing the impact of the Shockwave Medical acquisition on AVS.
On Point
Robert Chisena on point discussing the point of differentiation of AVS' Pulse IVL™ therapy.
On Point
Sean Gilligan on point discussing the balancing act of urgency and discipline when commercializing a medical device.
On Point
Robert Chisena on point discussing the mechanism of action behind AVS' Pulse IVL™ technology.
On Point
Sean Gilligan on point discussing the enabling technologies for intravascular lithotripsy.
On Point
Robert Chisena on point discussing AVS' path from university lab to venture funded start-up.
On Point
Robert Chisena on point discussing the benefits of proximity for biomedical engineering programs to healthcare systems.
On Point
Sean Gilligan on point discussing the rapid adoption of new technology in the healthcare industry.
On Point
Robert Chisena on point discussing the benefits of adversity to entrepreneurs and start-ups.
On Point
Robert Chisena on point answering rapid fire questions from Brian Johnson.
Behind the Scenes
.webp?width=1921&height=1081&name=Content%20Card%20-%20Just%20Mighty%20-%20Boyd%20-%20Two%20Color%20-%20Full%20(1920%20x%201080).webp)
.png?width=401&height=401&name=Logo%20-%20Just%20Mighty%20-%20White%20Logo%20(400%20x%20400).png){kind=logo}